Skip to main content

A Workshop on Biomarkers and Other Pre-clinical Diagnostics of Alzheimer's Disease

Completed

The National Academies will host a two-day workshop on the implications for behavioral and social research and clinical practice from emerging knowledge of biomarkers and other pre-clinical diagnostics of Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD). An expert planning committee will develop the agenda for the workshop, anticipated to be held June 2021 in Washington, DC. This workshop may include discussions of affordability, impact on health services, ethical implications, effects on prevention trials, and health equity issues. A proceedings in brief of the workshop presentations and discussions will be available for download once released to the public.

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.